Crossmark

LK-1: an investigational therapy targeting hCG-β in metastatic breast, bladder, ovarian, and cervical cancers

Published Online: 2026-02-20

Authors

Kinion, J. Helena

McAllister, Michael B.

Summerton, James E.

Dolan, Brian P.
License Information

Text and Data Mining valid from 2026-02-20

Accepted Manuscript valid from 2026-02-20
More Information

Article History

Received: 14 April 2025

Accepted: 31 January 2026

First Online: 20 February 2026

Declarations

:

: Authors Dr. Kinion and Dr. Summerton are the inventors in a patent related to the content of this manuscript. The other authors declare no competing interests.

Document is current